KOMISJA NADZORU FINANSOWEGO
Raport bieżący nr2/2021
Data sporządzenia: 2021-01-06
Skrócona nazwa emitenta
MILESTONE MEDICAL
Temat
The Update on Commercial Rollout of CompuFlo® Epidural System
Podstawa prawna
Art. 17 ust. 1 MAR - informacje poufne.
Treść raportu:
The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company”, “the Issuer”) today today provided the update on commercial rollout of CompuFlo® Epidural System. The Board of Directors of the Issuer is pleased to report that the Company is gaining traction with its CompuFlo® Epidural System. Specifically, the Company announced it has begun selling CompuFlo® disposables to the University of Texas Medical Branch at Galveston (UTMB), an institution of the University of Texas System and agency of the State of Texas. The Board of Directors of the Issuer anticipates adding additional hospitals during the first quarter of 2021 and remains steadfast in its goal of establishing the CompuFlo® Epidural System as the new standard of care in epidural anesthesia. Given the strong cash position at the end of the third quarter of its parent, The Board of Directors of the Issuer believes that the Company is well funded to support its sales and marketing activities around the CompuFlo® Epidural System and have no plans to raise capital for the foreseeable future.
MESSAGE (ENGLISH VERSION)
MILESTONE MEDICAL INC
(pełna nazwa emitenta)
MILESTONE MEDICAL
(skrócona nazwa emitenta)(sektor wg. klasyfikacji GPW w W-wie)
NJ 07039.
(kod pocztowy)(miejscowość)
South Orange Avenue Livingston220
(ulica)(numer)
+11 973 535 2717+11 973 535 2829
(telefon)(fax)
(e-mail)(www)
27-5484393
(NIP)(REGON)
PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ
DataImię i NazwiskoStanowisko/FunkcjaPodpis
2021-01-06Joseph D'AgostinoJoseph D'AgostinoChief Financial Officer